welcome
Working for the people to improve healthcare

CIBBIM-Nanomedicine Director

Dr. Simó Schwartz Jr


Nanomedicine and Advanced Therapies as translational sciences have the ultimate goal to provide cost effective novel therapies and diagnostics. As key enable technologies these new options will cause profound changes in healthcare, making feasible more personalized, predictive, preventive, and regenerative medicine.

PRECLINICAL SERVICES

This platform offers standard in vitro experimentation procedures for the functional validation of candidate genes and biomarkers, and for the efficacy and toxicological evaluation of new drugs, biomaterials and biomarkers.
Read more

At the moment, the platform offers standardin vivo experimentation procedures for the evaluation of new therapeutic targets, nanotherapies and biomarkers in the field of oncology and rare diseases.
Read more

Latest
news

News

The Area of Functional Validation & Preclinical Research of CIBBIM-Nanomedicine obtains the ISO 9001:2008 certification of Quality Management System

The Area of Functional Validation & Preclinical Research of CIBBIM-Nanomedicine obtains the ISO 9001:2008 certification of Quality Management System

This January, the Area of Functional Validation & Preclinical Research (FVPR) of CIBBIM-Nanomedicine has obtained the ISO 9001:2008 certification of Quality...

Read more
Asdent donates more than 114,000 euros for the investigation of Dent’s disease in Vall d’Hebron

Asdent donates more than 114,000 euros for the investigation of Dent’s disease in Vall d’Hebron

Asdent (Association of Dent Disease) has delivered 114,978.55 euros to the Vall d’Hebron Research Institute (VHIR) to continue researching this disease. The...

Read more
Nanomedicine & Bioengineering

Publications

Diverse Applications of Nanomedicine.

Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, Bosi S, Carril M, Chan WC, Chen C, Chen X, Chen...

Read more